Skip to main content
Log in

Adherence to NICE schizophrenia guideline improves outcomes, reduces cost

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Jin H, et al. Cost and health impacts of adherence to the National Institute for Health and Care Excellence schizophrenia guideline recommendations. British Journal of Psychiatry : 1-6, 14 Dec 2020. Available from: URL: http://doi.org/10.1192/bjp.2020.241

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adherence to NICE schizophrenia guideline improves outcomes, reduces cost. PharmacoEcon Outcomes News 869, 2 (2021). https://doi.org/10.1007/s40274-021-7369-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7369-9

Navigation